--- title: "If You Invested $1000 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today" type: "News" locale: "en" url: "https://longbridge.com/en/news/296656460.md" description: "Investing $1,000 in Royalty Pharma (RPRX) ten years ago would yield approximately $30,202 today. The stock has outperformed the market with an annualized return of 40.75% over the decade. Currently valued at a $27.3 billion market cap, this performance highlights the significant impact of compounded returns on long-term cash growth." datetime: "2026-08-21T21:15:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296656460.md) - [en](https://longbridge.com/en/news/296656460.md) - [zh-HK](https://longbridge.com/zh-HK/news/296656460.md) generator: "portal-rs" --- # If You Invested $1000 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 27.34% on an annualized basis producing an average annual return of 40.75%. Currently, Royalty Pharma has a market capitalization of $27.30 billion. **Buying $1000 In RPRX:** If an investor had bought $1000 of RPRX stock 10 years ago, it would be worth **$30,201.97** today based on a price of $61.31 for RPRX at the time of writing. ### Royalty Pharma’s Performance Over Last 10 Years ![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/08/21/024523032a7a72e9f33731fef8fcdaf8.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. *This article was generated by Benzinga's automated content engine and reviewed by an editor.* ### Related Stocks - [RPRX.US](https://longbridge.com/en/quote/RPRX.US.md) ## Related News & Research - [Is Royalty Pharma (RPRX) Undervalued On Its $100 Million Zealand Pharma Royalty Deal?](https://longbridge.com/en/news/296647266.md) - [Here’s How Much You Would Have Made Owning Royalty Pharma Stock In The Last 10 Years](https://longbridge.com/en/news/295983710.md) - [Royalty Pharma CFO Terrance P. Coyne sells USD 645,248 in common shares](https://longbridge.com/en/news/296146007.md) - [Royalty Pharma EVP and Chairman of Partnering Christopher Hite sells 100,000 shares for $6 million](https://longbridge.com/en/news/296396564.md) - [$1000 Invested In Deere 10 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296667925.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**